·¬ΗΡΚΣΖ΅

Meeting Coverage

AAO

American Academy of Ophthalmology

At-Home Monitoring for Age-Related Macular Degeneration Gets High Marks

No change in visual acuity, office-visit interval almost doubled during 6 months

AAO over a photo of the Moscone Center in San Francisco, CA.

Latest AAO Meeting Coverage

Ocular Implant Producing Neurotrophic Factor Preserves Central Vision in MacTel

Significant decrease in rate of photoreceptor loss in two randomized trials

November 8, 2023
Neuroprotective Agent Prevents Significant Vision Loss in Geographic Atrophy

Consistent vision effect with complement C1q inhibitor, despite no effect on lesion size

November 7, 2023
VEGF-Targeted Antibody Conjugate Gets a Win in Nonproliferative Diabetic Retinopathy

Some degree of improvement in disease status in 70% of patients treated with tarcocimab

November 6, 2023
Gene Therapy Controls Diabetic Eye Disease for at Least a Year

All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement

November 6, 2023
Eye Drops Make Bid for Role in Diabetic Macular Edema

Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned

November 5, 2023
AAO Roundup: Glaucoma Subtype Linked to Alzheimer's Disease Risk

Other studies report fewer reoperations with combo eye surgery and vision risk with shingles

October 6, 2022
Anti-VEGF Conjugate Gets a Win in Retinal Vein Occlusion

Tarcocimab noninferior to aflibercept while cutting treatment burden in half

October 4, 2022
Surgery Plus Stent Slows Glaucoma Progression Better Than Surgery Alone

Five-year follow-up shows significantly less annual visual field progression with the stent

October 4, 2022
Traditional Glaucoma Surgery Tops MIGS for Treatment Success

Twice as many patients met IOP goals with TIGS, but confounders complicated data analysis

October 3, 2022
Therapeutic Candidates for Dry AMD Move Closer to Clinical Practice

Slowing of geographic atrophy at 1 and 2 years with pegcetacoplan, avacincaptad pegol

October 3, 2022
Higher Dose, Longer Treatment Interval With Aflibercept Shows Promise in Eye Disease

Dosing 8 mg every 12 or 16 weeks for DME, AMD matches results with 2 mg every 8 weeks

October 2, 2022
What to Expect at This Year's American Academy of Ophthalmology Meeting

Maria Aaron, MD, previews the programs and studies at the 2022 meeting in Chicago

September 25, 2022
Microstent for Cataract Surgery Reduced Need for Glaucoma Meds

Device lowers eye pressure by promoting fluid flow through Schlemm's canal

November 17, 2021
COVID-19 Linked to Long List of Eye Abnormalities

Indian eye doctors also warn of dangerous infections associated with steroids, diabetes

November 16, 2021

Videos

AAO Video Pearls
November 2023